v3.26.1
Note to the cash flow statement (Details) - EUR (€)
€ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Adjustment for non-cash transactions      
Depreciation and impairment. € 55,875 € 45,499 € 43,642
Impairment of the cell therapy business 228,112    
Share-based compensation expenses 23,999 19,886 56,718
Increase/decrease (-) in retirement benefit obligations and provisions (2,352) (524) 11
Unrealized exchange losses/gains (-) and non-cash other financial result 43,836 (23,858) 19,908
Discounting effect of non-current deferred income   (227) (645)
Discounting effect of other non-current liabilities 1,183 (395) (318)
Discounting effect of contingent consideration receivable (2,676) (4,002)  
Fair value re-measurement of warrants   (4) (18)
Net change in fair value of current financial investments 51,911 (49,984) (22,690)
Fair value adjustment financial assets held at fair value through profit or loss (1,175)   390
Fair value adjustment contingent consideration receivable (11,887) (931)  
Fair value adjustment contingent consideration payable (21,760)    
Other non-cash expenses (151) (12) 2,292
Impairment loss on trade receivables (9,643) 9,643  
Total adjustment for non-cash transactions 127,160 (4,909) 99,291
Interest expense 1,034 912 1,867
Interest income (46,339) (89,378) (79,319)
Tax expense (18,138) (1,705) 11,689
Correction for cash used for other liabilities related to the disposal of subsidiaries.   527  
Total adjustment for items to disclose separately under operating cash flow (63,443) (89,644) (65,763)
Gain on disposal of subsidiaries (1,085) (52,488)  
Gain (-)/loss on sale of fixed assets 27 8 (1,091)
Proceeds from settlement of hedging instrument (22,745)    
Investment Income related to current financial investments (33,645) (23,759) (15,597)
Correction for cash used for other liabilities related to the disposal of subsidiaries 15,194    
Total adjustment for items to disclose separately under investing and financing cash flow (42,254) (76,239) (16,688)
Increase in inventories 28,851 23,039 (24,076)
Increase (-)/ decrease in receivables 86,588 (31,055) (39,114)
Increase/decrease (-) in liabilities 33,813 (53,429) 31,817
Total change in working capital other than deferred income € 149,252 € (61,445) € (31,373)